Literature DB >> 24526785

Use of a patient preference predictor to help make medical decisions for incapacitated patients.

Annette Rid1, David Wendler.   

Abstract

The standard approach to treatment decision making for incapacitated patients often fails to provide treatment consistent with the patient's preferences and values and places significant stress on surrogate decision makers. These shortcomings provide compelling reason to search for methods to improve current practice. Shared decision making between surrogates and clinicians has important advantages, but it does not provide a way to determine patients' treatment preferences. Hence, shared decision making leaves families with the stressful challenge of identifying the patient's preferred treatment option. To address this concern, the present paper proposes to incorporate the use of a "Patient Preference Predictor" (PPP) into the shared decision-making process between surrogates and clinicians. A PPP would predict which treatment option a given incapacitated patient would most likely prefer, based on the individual's characteristics and information on what treatment preferences are correlated with these characteristics. Use of a PPP is likely to increase the chances that incapacitated patients are treated consistent with their preferences and values and might reduce the stress and burden on their surrogates. Including a PPP in the shared decision-making process therefore has the potential to realize important ethical goals for making treatment decisions for incapacitated patients. The present paper justifies this approach on conceptual and normative grounds.

Entities:  

Keywords:  advance care planning; advance directives; decisional incapacity; surrogates; treatment decision making

Mesh:

Year:  2014        PMID: 24526785     DOI: 10.1093/jmp/jhu001

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  9 in total

1.  Patients' priorities for treatment decision making during periods of incapacity: quantitative survey.

Authors:  Annette Rid; Robert Wesley; Mark Pavlick; Sharon Maynard; Katalin Roth; David Wendler
Journal:  Palliat Support Care       Date:  2014-10-02

2.  Numeracy and Interpretation of Prognostic Estimates in Intracerebral Hemorrhage Among Surrogate Decision Makers in the Neurologic ICU.

Authors:  Nikita Leiter; Melissa Motta; Robert M Reed; Temitope Adeyeye; Debra L Wiegand; Nirav G Shah; Avelino C Verceles; Giora Netzer
Journal:  Crit Care Med       Date:  2018-02       Impact factor: 7.598

3.  Improving medical decisions for incapacitated persons: does focusing on "accurate predictions" lead to an inaccurate picture?

Authors:  Scott Y H Kim
Journal:  J Med Philos       Date:  2014-02-19

4.  Guardianship and End-of-Life Decision Making.

Authors:  Andrew B Cohen; Megan S Wright; Leo Cooney; Terri Fried
Journal:  JAMA Intern Med       Date:  2015-10       Impact factor: 21.873

5.  A new method for making treatment decisions for incapacitated patients: what do patients think about the use of a patient preference predictor?

Authors:  David Wendler; Bob Wesley; Mark Pavlick; Annette Rid
Journal:  J Med Ethics       Date:  2016-01-29       Impact factor: 2.903

6.  A Call for a Patient Preference Predictor.

Authors:  David Wendler
Journal:  Crit Care Med       Date:  2021-06-01       Impact factor: 9.296

7.  Toward a sociology of finitude: life, death, and the question of limits.

Authors:  Roi Livne
Journal:  Theory Soc       Date:  2021-05-15

8.  Beyond cultural stereotyping: views on end-of-life decision making among religious and secular persons in the USA, Germany, and Israel.

Authors:  Mark Schweda; Silke Schicktanz; Aviad Raz; Anita Silvers
Journal:  BMC Med Ethics       Date:  2017-02-17       Impact factor: 2.652

9.  "SpezPat"- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians' understanding of non-small cell lung cancer patients' end-of-life decisions.

Authors:  Julia Felicitas Leni Koenig; Thomas Asendorf; Alfred Simon; Annalen Bleckmann; Lorenz Truemper; Gerald Wulf; Tobias R Overbeck
Journal:  BMC Palliat Care       Date:  2022-09-28       Impact factor: 3.113

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.